Department of Hematology, Saitama International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, Japan.
Leuk Res. 2010 Aug;34(8):974-80. doi: 10.1016/j.leukres.2009.11.015.
We reported the different clinical features between Japanese and German refractory anemia (RA) patients in FAB classification. We re-analyzed the clinical features by WHO classification revised in 2008. The frequencies of refractory cytopenia with unilineage dysplasia (RCUD) and myelodysplastic syndrome-unclassified (MDS-U) with pancytopenia in Japanese patients were higher than in German patients (p<0.001). Refractory cytopenia with multilineage dysplasia patients showed the most unfavorable prognosis in both countries. The higher frequencies of MDS-U with pancytopenia and RCUD in Japanese patients may influence the different clinical characteristics between Japanese and German FAB-RA patients.
我们报告了 FAB 分类中日德难治性贫血(RA)患者的不同临床特征。我们通过 2008 年修订的 WHO 分类重新分析了临床特征。日本患者难治性细胞减少伴单系发育异常(RCUD)和未分类骨髓增生异常综合征伴全血细胞减少(MDS-U)的频率高于德国患者(p<0.001)。两国患者中,多系发育异常难治性细胞减少症患者预后最差。日本患者 MDS-U 伴全血细胞减少和 RCUD 的较高频率可能影响日本和德国 FAB-RA 患者的不同临床特征。